The effect of Au injection on the ceruloplasmin, metallothionein and 8-hydroxydeoxyguanosine of rat serum, kidney and liver

Chemico-Biological Interactions

Volumn 140, Issue 3, 2002, Pages 265-278

  Saito, Shigeru ^a   Hiyamuta, Shuichi ^b   Kurasaki, Masaaki ^c   Saito, Takeshi ^d   Hosokawa, Toshiyuki ^c   Fujita, Hiroyoshi ^d   Yoshida, Katsumi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MARINE BIOTECHNOLOGY INSTITUTE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

8 Hydroxydeoxyguanosine; Ceruloplasmin; Gold injection; Metallothionein

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CERULOPLASMIN; COPPER; GOLD; METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; INJECTION; KIDNEY; KIDNEY CORTEX; LIVER; MALE; NONHUMAN; OXIDATION; RAT; SERUM;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD UREA NITROGEN; CERULOPLASMIN; COPPER; CREATININE; DEOXYGUANOSINE; GOLD; KIDNEY; LIVER; MALE; METALLOTHIONEIN; MICROSCOPY, CONFOCAL; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; ZINC;

EID: 0037102010     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(02)00047-9     Document Type: Article

References (64)

1. E. Frieden, Ceruloplasmin: A multi-functional metalloprotein of vertebrate plasma, in: Biological Roles of Copper, CIBA Foundation Symposium 79. Excerpta Medica, Amsterdam, 1980, pp. 93-124.
2. Messerschmidt A., Huber R. The blue oxidases, ascorbate oxidase, laccase and Cp. Modelling and structural relationships. Eur. J. Biochem. 187:1990;341-352.
3. Zaitsev V.N., Zaitseva I., Papiz M., Lindley P.F. An X-ray crystallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin, a multi-copper oxidase in the plasma. J. Biol. Inorg. Chem. 4:1999;579-587.
4. Raju K.S., Alessandri G., Ziche M., Gullino P.M. Cp, copper ions and angiogenesis. J. Natl. Cancer Inst. 69:1982;1183-1188.
5. Kushner I. The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389:1982;39-48.
6. Maury C.P.J. Tumour necrosis factor - an overview. Acta Med. Scand. 220:1986;291-294.
7. Chiou S.-H. DNA-scission activities of ascorbate in the presence of metal chelates. J. Biochem. 96:1984;1307-1310.
8. Sagripanti J.L., Kraemer K.H. Site-specific oxidative DNA damage at polyguanosine produced by copper plus hydrogen peroxide. J. Biol. Chem. 264:1989;1729-1734.
9. Yamamoto K., Kawanishi S. Hydroxyl free radical is not the main active species in site-specific DNA damage induced by copper (II) ion and hydrogen peroxide. J. Biol. Chem. 264:1989;15435-15440.
10. Stewart L.C., Klinman J.P. Dopamine beta-hydroxylase of adrenal chromaffin granules: structure and function. Annu. Rev. Biochem. 57:1988;551-592.
11. Bull P.C., Thomas J.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet. 5:1993;327-337.
12. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., Wasco W., Ross B., Romano D.M., Parano E., Pavone L., Brizustowicz L.M., Devoto M., Peppercorn J., Bush A.I., Sternlieb I., Piratsu M., Grusella J.F., Evgrafov O., Penchaszadeh G.K., Honig B., Edelman I.S., Soares M.B., Scheinberg I.H., Gilliam T.C. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genet. 5:1993;344-350.
13. Wu J., Forbes J.R., Chen H.S., Cox D.W. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nature Genet. 7:1994;541-545.
14. Li L., Togashi Y., Sato S., Emoto T., Kang J.-H., Takeichi N., Kobayashi H., Kojima Y., Une Y., Uchino J. Spontaneous hepatic copper accumulation in Long-Evans cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J. Clin. Invest. 87:1991;1858-1861.
15. Kojimahara N., Nakabayashi H., Ikeda T., Mori M., Shikata T., Esumi M. Defective copper binding to apo-Cp in a rat model and patients with Wilson's disease. Liver. 15:1995;135-142.
16. Danks D.M. Sternlieb J.B., Wyngaarden J.B., Fredrick D.S., Metabolic Basis of Inherited Disease. 1983;1251-1268 McGraw-Hill, New York.
17. Gibbs K., Walshe J.M. Biliary excretion of copper in Wilson's disease. Lancet. 2:1980;538-539.
18. Sugawara N., Li D., Sugawara C., Miyake H. Decrease in biliary excretion of copper in Long-Evans cinnamon (LEC) rats causing spontaneous hepatitis due to a gross accumulation of hepatic copper. Res. Commun. Chem. Pathol. Pharmacol. 81:1993;45-52.
19. Whanger P.D., Weswig P.H. Effect of some copper antagonists on induction of Cp in the rat. J. Nutr. 100:1970;341-348.
20. Hiyamuta S., Shimizu K., Aoki T. Early diagnosis of Wilson's disease. Lancet. 342:1993;56-57.
21. Vaamonde C.A., Hunt F.R. The nephrotic syndrome as a complication of gold therapy. Arthritis Rheumatol. 13:1970;826-834.
22. Silverberg D.S., Kidd E.G., Schnitke T.K., Ulan R.A. Gold nephropathy. A clinical and pathologic study. Arthritis Rheumatol. 13:1970;812-825.
23. McVty K.J., Shaikh Z.A. Subchronic treatment of rats with aurothioglucose; effects on plasma, hepatic, renal and urinary zinc, copper and metallothionein. Toxicology. 46:1987;295-306.
24. Saito S. The effect of gold on copper and zinc in kidney and in metallothionein. Res. Commun. Mol. Pathol. Pharmacol. 93:1996;171-176.
25. Kägi J.H.R. Evolution, structure and chemical activity of class I metallothionein: an overview. Suzuki K.T., Imura N., Kimura M., Metallothionein III. 1993;29-55 Birkhäuser Verlag, Basel/Switzerland.
26. Bremner I. Nutritional and physiological significance of metallothionein. Kägi J.H.R., Kojima Y., Metallothionein II. 1987;81-107 Birkhäuser Verlag, Basel/Switzerland.
27. Saito S., Okabe M., Kurasaki M. Localization of renal Cu-binding metallothionein induced by Au injection into rats. Biochem. Biophys. Acta. 1335:1997;353-358.
28. Mogilinicka E., Webb M. Comparative studies on the distribution of gold, copper and zinc in the livers and kidneys of rats and hamsters after treatment with sodium [195Au]-aurothiomalate. J. Appl. Toxicol. 1:1981;287-291.
29. Chiou S.H. DNA-scission activities of ascorbate in the presence of metal chelates. J. Biochem. 96:1984;1307-1310.
30. Sagripanti J.-L., Kraemer K.H. Site-specific oxidative DNA damage at polyguanosine produced by copper plus hydrogen peroxide. J. Biol. Chem. 264:1989;1729-1734.
31. Yamamoto K., Kawanishi S. Hydroxyl free radical is not the main active species in site-specific DNA damage. J. Biol. Chem. 264:1989;15435-15440.
32. Tkeshelashvili L.K., McBride T., Spence K., Loeb L.A. Mutation spectrum of copper-induced DNA damage. J. Biol. Chem. 266:1991;6401-6406.
33. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 11:1990;1447-1450.
34. Cerda S., Weitzman S.A. Influence of oxygen radical injury on DNA methylation. Mutat. Res. 386:1997;141-152.
35. Weitzman S.A., Turk P.W., Milkowski D.H., Kozlowski K. Free radical adducts induce alterations in DNA cytosine methylation. Proc. Natl. Acad. Sci. USA. 91:1994;1261-1264.
36. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A. 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G - T and A - C substitutions. J. Biol. Chem. 267:1992;166-172.
37. Kasai H., Nishimura S., Kurokawa Y., Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis. 8:1987;1959-1961.
38. Shen H.-M., Ong C.-N., Lee B.-L., Shi C.-Y. Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis. 16:1995;419-422.
39. Nagashima M., Kasai H., Yokota J., Nagamachi Y., Ichinose T., Sagai M. Formation of an oxidative DNA damage, 8-hydroxydeoxyguanosine, in mouse lung DNA after intratracheal instillation of diesel exhaust particles and effects of high dietary fat and beta-carotene on this process. Carcinogenesis. 16:1995;1441-1445.
40. Fung H., Kow Y.K., van Houten B., Mossman B.T. Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis. 18:1997;825-832.
41. Takeuchi T., Morimoto K. Crocidolite asbestos increased 8-hydroxyguanosine levels in DNA of a human promyelocytic leukemia cell line, HL60. Carcinogenesis. 15:1994;635-639.
42. Ogura H., Takeuchi T., Morimoto K. A comparison of the 8-hydroxyguanosine, chromosome aberrations and micronucleus techniques for the assessment of the genotoxicity of mercury compounds in human blood lymphocytes. Mutat. Res. 340:1996;175-182.
43. Okabe M., Hosokawa S., Saito S., Saito T., Kurasaki M. Histochemical studies on renal copper-metallothionein using confocal laser microscopy. Trace Elem. Electrolytes. 16:1999;61-66.
44. Hiyamuta S., Ito K. Monoclonal antibody against the active site of caeruloplasmin and the ELISA system detecting active caeruloplasmin. Hbyridoma. 13:1994;139-141.
45. Wroblewski F., LaDue J.S. Serum glutamic oxaloacetic transaminase activity as an index of liver cell injury. A preliminary report. Ann. Inter. Med. 43:1955;345-351.
46. Sharma R.P., McQueen E.G. Effects of gold sodium thiomalate on cytosolic copper and zinc in the rat kidney and liver tissues. Clin. Exp. Pharmacol. Physiol. 8:1981;591-599.
47. Schmitz G., Minkel D.T., Gingrich D., Shaw C.F. III. Quantitative immunohistochemical evaluation by image analysis of metallothionein in copper-loaded rat kidney. J. Inorg. Biochem. 12:1980;293-306.
48. Mogilnicka E., Webb M. Comparative studies on the distribution of gold, copper and zinc in the livers and kidneys of rats and hamsters after treatment with sodium [195Au]-aurothiomalate. Chem. Biol. Interact. 40:1982;247-256.
49. McVety K.J., Shaikh Z.A. Subchronic treatment of rats with aurothioglucose; effects on plasma, hepatic, renal and urinary zinc, copper and metallothionein. Toxicology. 46:1987;296-306.
50. Whanger P.D., Weswig P.H. Effect of some copper antagonists on induction of ceruloplasmin in the rat. J. Nutr. 100:1970;341-348.
51. Kurasaki M., Okabe M., Saito S., Yamanoshita O., Hosokawa T., Saito T. Histochemical characterization of silver-induced metallothionein in rat kidney. J. Inorg. Biochem. 78:2000;275-281.
52. Mercer J.F.B., Livingston J., Hall B., Paynter J.A., Begy C., Chandrasekharappa S., Lockhart P., Grimes A., Bhave M., Siemieniak D., Glover T.W., et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nature Genet. 3:1993;20-25.
53. Vulpe C., Livingston J., Whitney S., Packman S., Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nature Genet. 3:1993;7-13.
54. Li Y., Togashi Y., Sato S., Emoto T., Kang J.H., Takeichi N., Kobayashi H., Kojima Y., Une Y., Uchino J. Spontaneous hepatic copper accumulation in Long-Evans cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J. Clin. Invest. 87:1991;1858-1861.
55. Okabe M., Nakayama K., Kurasaki M., Yamasaki F., Aoyagi K., Yamanoshita O., Sato S., Okui T., Ohyama T., Kasai N. Direct visualization of copper-metallothionein in LEC rat kidneys: application of autofluoresence signal of copper-thiolate cluster. J. Histochem. Cytochem. 44:1996;865-873.
56. Suzuki-Kurasaki M., Okabe M., Kurasaki M. Copper-metallothionein in the kidney of macular mice: a model for Menkes disease. J. Histochem. Cytochem. 45:1997;1493-1501.
57. Kurasaki M., Okabe M., Saito S., Suzuki-Kurasaki M. Copper metabolism in the kidney of rats administered copper and copper-metallothionein. Am. J. Physiol. 274:1998;F783-F790.
58. Evering W.E., Haywood S., Elmens M.E., Jasani B., Trafford J. Histochemical and immunocytochemical evaluation of copper and metallothionein in the liver and kidney of copper-loaded rats. J. Pathol. 160:1990;305-312.
59. S. Saito, M. Masaaki, T. Hosokawa, M. Okabe, T. Saito, Y. Fujii, K. Nagashima, K. Yoshida, Localization of the induced metallothionein and DNA damage in rat kidney after gold injection, J. Histochem. Cytochem. 50 (2002) in press.
60. Stephenson G.F., Chart H.M., Cherian M.G. Copper-metallothionein from the toxic milk mutant mouse enhances lipid peroxidation initiated by an organic hydroperoxide. Toxicol. Appl. Pharmacol. 125:1994;90-96.
61. Oikawa S., Kurasaki M., Kojima Y., Kawahishi S. Oxidative and nonoxidative mechanisms of site-specific DNA cleavage induced by copper-containing metallothioneins. Biochemistry. 34:1995;8763-8770.
62. Deng D.X., Ono S., Koropatnick J., Cherian M.G. Metallothionein and apoptosis in the toxic milk mutant mouse. Lab. Invest. 78:1998;175-183.
63. Tamai K.T., Gralla E.B., Ellerby L.M., Valentine J.S., Thiele D.J. Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA. 90:1993;8013-8017.
64. Mercer J.F.B., Livingston J., Hall B., Paynter J.A., Begy C., Chandrasekharappa S., Lockhart P. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nature Genet. 3:1993;20-25.